Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    " March 30, 2011":" April 29, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Levels of Raltegravir in the Female Genital Tissue
Condition: HIV
Intervention: Drug: Raltegravir
22 Completed
Has Results
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
23 Completed Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus
Condition: HIV-1 Infection
Interventions: Drug: Cenicriviroc 100 mg;   Drug: Cenicriviroc 200 mg + Truvada;   Drug: Sustiva + Truvada
24 Completed
Has Results
Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1—Infected Patients
Condition: HIV, Combination Therapy
Interventions: Drug: Atazanavir;   Drug: Ritonavir (heat-stable);   Drug: Raltegravir;   Drug: Tenofovir/Emtricitabine
25 Completed TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.
Conditions: Hepatitis C;   HIV
Interventions: Drug: ETR/telaprevir;   Drug: TMC278/telaprevir;   Drug: telaprevir/ETR;   Drug: telaprevir/TMC278
26 Terminated
Has Results
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
Condition: HIV-1
Interventions: Drug: Maraviroc;   Drug: Emtricitabine/tenofovir;   Drug: darunavir/ritonavir 800/100 mg;   Drug: placebo for emtricitabine/tenofovir;   Drug: placebo for maraviroc
27 Completed Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
Conditions: HIV Infections;   Central Nervous System Diseases;   Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine;   Drug: tenofovir-lamivudine-efavirenz
28 Completed
Has Results
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Conditions: HIV;   Hepatitis C, Chronic;   HCV Coinfection
Intervention:
29 Unknown  Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma
Conditions: HIV;   Lymphoma
Intervention:
30 Completed Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
Conditions: Hazardous Drinking;   HIV
Intervention: Behavioral: Brief alcohol intervention
31 Completed Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)
Conditions: HIV;   Tuberculosis;   Pediatrics
Intervention: Other: Development of a diagnosis algorithm
32 Active, not recruiting Schooling, Income, and HIV Risk in Malawi
Conditions: HIV;   Schooling;   Conditional Cash Transfers;   Unconditional Cash Transfers
Intervention: Behavioral: Zomba Cash Transfer Program
33 Active, not recruiting Juvenile Justice Girls Randomized Control Trial: Young Adult Follow-up
Conditions: Delinquency;   Drug Use
Interventions: Behavioral: Treatment Foster Care (TFCO);   Behavioral: Group Care
34 Completed A Formative Study to Explore the Sensory Perceptions of Vaginal Product Users
Condition: Microbicide Delivery System Acceptability
Intervention:
35 Completed Recovery Management Checkups for Women Offenders
Conditions: Recovery Management Checkup (RMC);   Outcome Monitoring
Interventions: Behavioral: Recovery Management Checkups;   Other: Outcome Monitoring
36 Completed A Prospective Observational Study of the Performance of Zarin in Kenya
Condition: Contraceptive Usage
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Study has passed its completion date and status has not been verified in more than two years.